AquaBounty Technologies (NASDAQ:AQB) Shares Up 8% – What’s Next?

AquaBounty Technologies, Inc. (NASDAQ:AQB) shares traded up 8% during mid-day trading on Wednesday . The stock traded as high as $0.93 and last traded at $0.8530. 46,249 shares traded hands during trading, an increase of 77% from the average session volume of 26,089 shares. The stock had previously closed at $0.79.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of AquaBounty Technologies in a research report on Monday. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, AquaBounty Technologies currently has an average rating of “Sell”.

AquaBounty Technologies Stock Up 8.0%

The company has a 50 day simple moving average of $1.10 and a two-hundred day simple moving average of $1.09. The company has a market capitalization of $3.31 million, a P/E ratio of -1.03 and a beta of 1.36.

AquaBounty Technologies (NASDAQ:AQB) last posted its quarterly earnings data on Tuesday, October 28th. The company reported ($0.36) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.62) by $0.26.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in AquaBounty Technologies stock. Two Sigma Investments LP bought a new position in AquaBounty Technologies, Inc. (NASDAQ:AQB) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 37,565 shares of the company’s stock, valued at approximately $84,000. Two Sigma Investments LP owned about 0.97% of AquaBounty Technologies at the end of the most recent quarter. 8.92% of the stock is owned by hedge funds and other institutional investors.

About AquaBounty Technologies

AquaBounty Technologies, Inc is a biotechnology company focused on aquaculture innovation through the development and commercialization of genetically engineered fish. Its flagship product, AquAdvantage Salmon, is an Atlantic salmon strain enhanced with a growth hormone gene that enables faster growth and more efficient feed conversion compared with conventional farmed salmon. By integrating biotechnology into seafood production, AquaBounty aims to address global protein demand while reducing the environmental footprint associated with marine aquaculture.

Founded in 1991, AquaBounty is headquartered in Maynard, Massachusetts, and operates a state-of-the-art, land-based incubation and grow-out facility in Panama.